Transgene to Present Preclinical Data on Novel TG-MVA Prophylactic Vaccine Against mpox at the World Congress on Infectious Diseases

TG-MVA builds on Transgene’s expertise in MVA (Modified Vaccinia Ankara) viral vectors, which are well established in smallpox vaccines ...
Opinion

A New Hantavirus Vaccine Is in the Works

Since 2023, Moderna and Korea University have been developing a new mRNA vaccine for hantavirus. The work has been promising so far, but a finished product isn't likely coming any time soon.
Nasdaq

Tonix Pharmaceuticals Presents Promising Preclinical Data for TNX-801 Vaccine Against Mpox and Smallpox at World Vaccine Congress 2025

Tonix Pharmaceuticals presented positive preclinical data for TNX-801, a single-dose vaccine against mpox and smallpox, at a recent conference. Tonix Pharmaceuticals has presented encouraging ...
Business Wire

ImmunoPrecise Advances AI Discovered and Developed Universal Dengue Vaccine Initiative: Moves into Preclinical Antibody Generation

The manufactured product will be used in proprietary immunization protocols at IPA’s Canadian facility. These studies, conducted in a rabbit model, are designed to evaluate whether the vaccine ...

Scientists are working on a hantavirus vaccine — but it’s likely years away

A hantavirus vaccine is currently in preclinical development, but a publicly available shot is likely years away. Other similar research efforts are also in the very early stages.

Bundibugyo Ebola vaccines and treatments in development

Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic ...
Scientific American

Ebola vaccines exist, but not for the strain in the current outbreak

A decade after Ebola vaccines changed outbreak response, a new epidemic in central Africa is caused by a strain the world ...

HDT Bio and UTMB Receive MCDC Innovation Prototype Award for Advancing CCHF Vaccine from Lab to Phase 1 Clinical Trial

HDT Bio, a clinical-stage biotechnology company based in Seattle, Washington, today announced that it received the Medical CBRN Defense Consortium (MCDC) Innovation Prototype Award. The award ...
Seeking Alpha

ProMIS Neurosciences Showcases Preclinical Data on Platform Derived Vaccines for Neurodegenerative Diseases at the American Academy of Neurology 2025 Annual Meeting

CAMBRIDGE, Massachusetts, March 13, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics ...